Comments
Loading...
Genetic Technologies (GENE) Forecast
NewsEarningsGenetic Technologies (GENE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGenetic Technologies (NASDAQ:GENE) Stock Quotes, Forecast and News Summary
Genetic Technologies Stock (NASDAQ: GENE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Genetic Technologies (GENE) stock?
You can purchase shares of Genetic Technologies (NASDAQ:GENE) through any online brokerage.
Who are Genetic Technologies (GENE) competitors?
Other companies in Genetic Technologies’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS) and Waters (NYSE:WAT).
What is the forecast, or price target, for Genetic Technologies (GENE) stock?
There is no analysis for Genetic Technologies to provide a consensus price target.
What is the current price for Genetic Technologies (GENE)?
The stock price for Genetic Technologies (NASDAQ: GENE) is $0.75 last updated October 16, 2024 at 6:56 PM EDT.
Does Genetic Technologies (GENE) pay a dividend?
There are no upcoming dividends for Genetic Technologies.
When is Genetic Technologies (NASDAQ:GENE) reporting earnings?
Genetic Technologies’s Q4 earnings are confirmed for Thursday, February 13, 2025.
Is Genetic Technologies (GENE) going to split?
There is no upcoming split for Genetic Technologies.
What sector and industry does Genetic Technologies (GENE) operate in?
Genetic Technologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.